Lipid profile in antipsychotic drug users: A comparative study

<div><p class="abstract"><strong>BACKGROUND:</strong> Schizophrenic patients who receive antipsychotic drugs may be highly prone to metabolic disorders such as weight gain, dyslipidemia, and insulin resistance. The objective of the present study was to compare the e...

Full description

Bibliographic Details
Main Authors: Hamidreza Roohafza, Azam Khani, Hamid Afshar, Mohammad Garakyaraghi, Afshin Amirpour, Basir Ghodsi
Format: Article
Language:English
Published: Vesnu Publications 2013-05-01
Series:ARYA Atherosclerosis
Online Access:http://arya.mui.ac.ir/index.php/arya/article/view/616
id doaj-a2ed20e95e894c9e8331f2ea16c93e2d
record_format Article
spelling doaj-a2ed20e95e894c9e8331f2ea16c93e2d2020-11-24T20:55:21ZengVesnu PublicationsARYA Atherosclerosis1735-39552251-66382013-05-0193198202402Lipid profile in antipsychotic drug users: A comparative studyHamidreza Roohafza0Azam Khani1Hamid Afshar2Mohammad Garakyaraghi3Afshin Amirpour4Basir Ghodsi5Assistant Professor, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IranResearch Assistant, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IranAssociate Professor, Psychosomatic Research Center, Isfahan University of Medical Sciences, Isfahan, IranHypertension Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IranAssistant Professor, Department of Mental Health, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IranResearch Assistant, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran<div><p class="abstract"><strong>BACKGROUND:</strong> Schizophrenic patients who receive antipsychotic drugs may be highly prone to metabolic disorders such as weight gain, dyslipidemia, and insulin resistance. The objective of the present study was to compare the effect of atypical and conventional antipsychotics on lipid profile.</p> <p class="abstract"><strong>METHODS:</strong> 128 schizophrenic patients were enrolled into the study. Patients were divided into two groups. One group had received one type of atypical antipsychotic drug, and, the other, one type of conventional antipsychotic drug. They were considered as atypical and conventional groups. Moreover, both groups had not used any other antipsychotic drugs during the past year. Demographic data and food frequency questionnaire were completed by the participants. Serum triglyceride, total cholesterol (TC), high-density lipoprotein and low-density lipoprotein (LDL) cholesterols, and apolipoprotein A and B (Apo B) were tested by blood sample drawing after 12 hours of fasting through the antecubital vein. Student&rsquo;s t-test was used to compare atypical and conventional groups.</p> <p class="abstract"><strong>RESULTS:</strong><strong> </strong>There was no significant difference in age, gender, duration of illness, period of drug consumption, and age at onset of illness in the two groups. Patients in the atypical group used clozapine and risperidone (46.9%) more than olanzapine. In the conventional group 81.3% of patients used phenothiazines. Comparison between lipid profile in the conventional and atypical groups showed a significantly higher mean in TC (P = 0.01), LDL (P = 0.03), and Apo B <br /> (P = 0.01) in conventional group than the atypical group.</p> <p class="abstract"><strong>CONCLUSION:</strong> In schizophrenic patients, the level of lipid profile had been increased in both atypical and conventional antipsychotic users, especially conventional users, so the effect of antipsychotic drugs should be investigated periodically.</p> <p class="abstract">&nbsp;</p> <p class="abstract"><strong>Keywords:</strong> Atypical Antipsychotic, Conventional Antipsychotic, Lipid Profile</p></div>http://arya.mui.ac.ir/index.php/arya/article/view/616
collection DOAJ
language English
format Article
sources DOAJ
author Hamidreza Roohafza
Azam Khani
Hamid Afshar
Mohammad Garakyaraghi
Afshin Amirpour
Basir Ghodsi
spellingShingle Hamidreza Roohafza
Azam Khani
Hamid Afshar
Mohammad Garakyaraghi
Afshin Amirpour
Basir Ghodsi
Lipid profile in antipsychotic drug users: A comparative study
ARYA Atherosclerosis
author_facet Hamidreza Roohafza
Azam Khani
Hamid Afshar
Mohammad Garakyaraghi
Afshin Amirpour
Basir Ghodsi
author_sort Hamidreza Roohafza
title Lipid profile in antipsychotic drug users: A comparative study
title_short Lipid profile in antipsychotic drug users: A comparative study
title_full Lipid profile in antipsychotic drug users: A comparative study
title_fullStr Lipid profile in antipsychotic drug users: A comparative study
title_full_unstemmed Lipid profile in antipsychotic drug users: A comparative study
title_sort lipid profile in antipsychotic drug users: a comparative study
publisher Vesnu Publications
series ARYA Atherosclerosis
issn 1735-3955
2251-6638
publishDate 2013-05-01
description <div><p class="abstract"><strong>BACKGROUND:</strong> Schizophrenic patients who receive antipsychotic drugs may be highly prone to metabolic disorders such as weight gain, dyslipidemia, and insulin resistance. The objective of the present study was to compare the effect of atypical and conventional antipsychotics on lipid profile.</p> <p class="abstract"><strong>METHODS:</strong> 128 schizophrenic patients were enrolled into the study. Patients were divided into two groups. One group had received one type of atypical antipsychotic drug, and, the other, one type of conventional antipsychotic drug. They were considered as atypical and conventional groups. Moreover, both groups had not used any other antipsychotic drugs during the past year. Demographic data and food frequency questionnaire were completed by the participants. Serum triglyceride, total cholesterol (TC), high-density lipoprotein and low-density lipoprotein (LDL) cholesterols, and apolipoprotein A and B (Apo B) were tested by blood sample drawing after 12 hours of fasting through the antecubital vein. Student&rsquo;s t-test was used to compare atypical and conventional groups.</p> <p class="abstract"><strong>RESULTS:</strong><strong> </strong>There was no significant difference in age, gender, duration of illness, period of drug consumption, and age at onset of illness in the two groups. Patients in the atypical group used clozapine and risperidone (46.9%) more than olanzapine. In the conventional group 81.3% of patients used phenothiazines. Comparison between lipid profile in the conventional and atypical groups showed a significantly higher mean in TC (P = 0.01), LDL (P = 0.03), and Apo B <br /> (P = 0.01) in conventional group than the atypical group.</p> <p class="abstract"><strong>CONCLUSION:</strong> In schizophrenic patients, the level of lipid profile had been increased in both atypical and conventional antipsychotic users, especially conventional users, so the effect of antipsychotic drugs should be investigated periodically.</p> <p class="abstract">&nbsp;</p> <p class="abstract"><strong>Keywords:</strong> Atypical Antipsychotic, Conventional Antipsychotic, Lipid Profile</p></div>
url http://arya.mui.ac.ir/index.php/arya/article/view/616
work_keys_str_mv AT hamidrezaroohafza lipidprofileinantipsychoticdrugusersacomparativestudy
AT azamkhani lipidprofileinantipsychoticdrugusersacomparativestudy
AT hamidafshar lipidprofileinantipsychoticdrugusersacomparativestudy
AT mohammadgarakyaraghi lipidprofileinantipsychoticdrugusersacomparativestudy
AT afshinamirpour lipidprofileinantipsychoticdrugusersacomparativestudy
AT basirghodsi lipidprofileinantipsychoticdrugusersacomparativestudy
_version_ 1716791676958146560